 |
Piritrexim isethionate |
|---|---|
| Trade Name | |
| Orphan Indication | Infections caused by Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium-intracellulare |
| USA Market Approval | USA |
| USA Designation Date | 1988-06-13 00:00:00 |
| Sponsor | Burroughs Wellcome Company;3030 Cornwallis Road, P.O. Box 12700;Research Triangle Park, North Carolina, 27709 |
